The number of people with susceptibility test result for rifampicin in Colombia
Colombia: The number of people with susceptibility test result for rifampicin was 39.17 in 2021. ▲ Rising
Latest (2021)
39.17
Change on year
up 88.5%
World rank
125th
of 146 countries
All-time high
39.17
in 2021
All-time low
20.79
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Colombia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Colombia recorded 39.17 for the number of people with susceptibility test result for rifampicin in 2021. That is the highest value across all 5 years on record.
That represents a change of up 88.5% on the previous year and up 83.7% over five years.
Colombia ranks 125th of 146 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Colombia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 21.32 | — |
| 2018 | 21.87 | +2.6% |
| 2019 | 22.91 | +4.8% |
| 2020 | 20.79 | -9.3% |
| 2021 | 39.17 | +88.5% |
Colombia compared with similar countries
- Colombia's 39.17 is below the median for upper middle income countries, which is 92.7, 42% of the median. (45 countries reporting)
- Colombia's 39.17 is below the median for Latin America & Caribbean, which is 59.38, 66% of the median. (21 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 22.03 | 21.32 | 22.91 | 3 |
| 2020s | 29.98 | 20.79 | 39.17 | 2 |
Countries ranked near Colombia
More health data for Colombia
- Un projection of annual infant deaths, annual growth rate -1.83 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3468 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,505 deaths per 1,000 people (2090)
- Number of infants who die before age 1 698 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Population ages 00-04, female, annual growth rate -0.3706 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0324 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.3776 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Colombia?
- The number of people with susceptibility test result for rifampicin in Colombia was 39.17 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Colombia?
- The highest recorded value was 39.17 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Colombia?
- The lowest recorded value was 20.79 in 2020.
- How does Colombia rank for the number of people with susceptibility test result for rifampicin?
- Colombia ranks 125th out of 146 countries with data for 2021.
- Where does this Colombia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).